Patents by Inventor Emi Takamitsu

Emi Takamitsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KIT FOR EVALUATING A GENE MUTATION RELATED TO MYELOPROLIFERATIVE NEOPLASMS
    Publication number: 20220282314
    Abstract: This invention is intended to accurately determine the presence or absence of a plurality of types of gene mutations in CALR or JAK2 among gene mutations related to myeloproliferative neoplasms. A CALR mutation probe reacts with any of the type 1, type 3, type 4, or the type 5 mutation related to myeloproliferative neoplasms and has a mismatch resulting from artificial deletion. Probes for JAK2 mutation encompass a V617F mutation probe and an exon 12 mutation probe.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 8, 2022
    Applicant: TOYO KOHAN CO., LTD.
    Inventors: Emi TAKAMITSU, Midori YOSHIMURA, Mitsuyoshi OBA
  • KIT FOR EVALUATING GENE MUTATION RELATED TO MYELOPROLIFERATIVE TUMOR
    Publication number: 20200190595
    Abstract: The present invention easily identifies a genotype for gene mutations related to myeloproliferative neoplasms. The present invention comprises a mutant probe that specifically hybridizes with a gene mutation related to myeloproliferative neoplasms in JAK2, a mutant probe that specifically hybridizes with a gene mutation related to myeloproliferative neoplasms in CALR, and a mutant probe that specifically hybridizes with a gene mutation related to myeloproliferative neoplasms in MPL.
    Type: Application
    Filed: June 28, 2018
    Publication date: June 18, 2020
    Applicants: Toyo Kohan Co., Ltd., Yamaguchi University
    Inventors: Emi Takamitsu, Mitsuyoshi Oba, Junichi Morihiro, Hirofumi Yamano, Toshiaki Yujiri, Masafumi Matsuguma